Font Size: a A A

Effect Of Transcatheter Arterial Chemoembolization On Inhibitor Of Apoptosis Protein-Survivin And Survivin MRNA In Hepatocellular Carcinoma

Posted on:2007-06-24Degree:MasterType:Thesis
Country:ChinaCandidate:Z WenFull Text:PDF
GTID:2144360185952202Subject:Surgery
Abstract/Summary:PDF Full Text Request
Objective: To study the effect of transcatheter arterial chemoembolization on inhibitor apoptosis protein-Survivin and Survivin mRNA in hepatocellular carcinoma, and the relationship between Survivin and apoptosis in hepatocellular carcinoma.Methods: Group of hepatocellular carcinoma with preoperative transcatheter arterial chemoembolizaton 26 cases(A group; TACE group),Group of hepatocellular carcinoma without TACE 30 cases(B group; only operation group),group of Normal liver tissue 16 cases (C group; normal group) .In situ hybridization was used to detect the expression of Survivin mRNA; Immunohistochemical S-P method was used to detect the expression of Survivin; Terminal deoxynucleotidyl transferase mediated dUTP nick end labeling(TUNEL) was used to detect the apoptosis of hepatocellular carcinoma.Result: 1,The positive Survivin mRNA expression is observed in 14 out of 26(53.85%) in the tissues of carcinoma in A group, and 24 out of 30(80.00%) in the tissues of carcinoma in B group. There is significant difference between these two groups(P<0.05);The grey difference is 19.32±4.16 in the tissues of carcinoma in A group, and 31.80±5.58 in the tissues of carcinoma in B group. There is significant difference between these two groups(P<0.05). There is no expression of Survivin mRNA in the matched adjacent nontumor tissues in A,B group and the normal liver tissues. 2,The positive Survivin expression is observed in 12 out of 26(46.15%) in the tissues of carcinoma in A group, and 22 out of 30(73.33%) in the tissues of carcinoma in B group. There is significant difference between these two groups(P < 0.05);The grey difference is...
Keywords/Search Tags:Transcatheter arterial chemoembolization, Hepatocellular carcinoma, Survivin, Apoptosis
PDF Full Text Request
Related items
The Value Of IVIM And DCE-MR In Patients With Hepatocellular Carcinoma Treat With Transcatheter Arterial Chemoembolization
Application Of GSI For Display Blood-supply Artery Of Residual Lesions And Diagnosis Hypo-vascular Liver Neoplasms In Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Treatment
The Change Of Serum Cytokines Before And After Transcatheter Arterial Chemoembolization And Its Significance In Hepatocellular Carcinoma
Efficacy And Safety Of Raltitrexed-based Transcatheter Arterial Chemoembolization For Intermediate And Advanced Hepatocellular Carcinoma Through Real-world Study
The Utility Of Serum PIVKA-??AFP?AFP-L3 And Other Indicators In Efficacy Surveillance And Recurrence Prediction After Transcatheter Arterial Chemoembolization In Treating Hepatocellular Carcinoma
Patient Survival And Tumour Recurrence With Transcatheter Arterial Chemoembolization After Hepatectomy For Hepatocellular Carcinoma: A Single-center Large Case Follow-up Study
Combination Of Transcatheter Arterial Chemoembolization And Radiofrequency Ablation In Treatment Of Primary Hepatocellular Carcinoma:An Analysis Of Curative Effect
Clinical Research Of Apatinib Combined With Transcatheter Arterial Chemoembolization In Treatment Of Intermediate And Advanced Hepatocellular Carcinoma
Clinical Studies Of DC-CIK Cells Were Co-cultured With Transcatheter Hepatic Arterial Chemoembolization For Middle-late Stage Hepatocellular Carcinoma
10 Clinical Study Of Apatinib Combined With Transcatheter Arterial Chemoembolization In Patients With Advanced Hepatocellular Carcinoma